Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Coherus Oncology, Inc. CHRS NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
46/100
2/7 Pass
SharesGrow Intrinsic Value
$1,395.48
+77426.7%
Analyst Price Target
$6.02
+234.4%

Coherus Oncology, Inc. (CHRS) has 10 identified peers for comparison in the Healthcare sector. Peers include ACHL, ASMB, BOLT, CTMX, GRCL, NLTX and others.

CHRS has a market capitalization of $210.86M, compared to an average peer market cap of $344.93M.

People Also View

NUVB
NUVB
Nuvation Bio Inc.
$4.85
+3.19%
 CTMX
CTMX
CytomX Therapeutics, Inc.
$4.54
+3.42%
 ASMB
ASMB
Assembly Biosciences, Inc.
$29.44
+0.68%
 GRCL
GRCL
Gracell Biotechnologies Inc.
$10.25
+0.05%
 SPRO
SPRO
Spero Therapeutics, Inc.
$2.78
-0.36%
 ACHL
ACHL
Achilles Therapeutics plc
$1.48
+0.68%
 TIL
TIL
Instil Bio, Inc.
$8.44
+1.02%
 NXTC
NXTC
NextCure, Inc.
$12.77
+3.65%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message